COCP vs GSK · rev $105.0K vs P/E 13, $103.31B cap
Cocrystal Pharma Inc (COCP) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
GSK does not have a complete income-statement cache yet.
COCP currently screens at market cap $13.3M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the COCP and GSK stock pages for the full models.
Not investment advice.